Please login to the form below
New accounts: March
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period December 2004 to February 2005 inclusive.
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period December 2004 to February 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail nhobson@pmlive.com.
|
|
|
|
|
|
Abbott Laboratories |
Humira |
Rheumatoid arthritis |
Brader Perryman |
|
Altana Pharma |
Alvesco |
Asthma |
Medicus London |
|
AstraZeneca |
Faslodex |
Oncology |
Brader Perryman |
|
Crookes Healthcare |
Pre-launch (x3) |
Pre-launch |
Medicus London |
|
Eden Biodesign |
N/A |
Corporate |
Affiniti (UK) |
|
Eisai |
Zonegran |
Epilepsy |
Brader Perryman |
|
Ferring |
Norprolac |
Hyperprolactinaemia |
Medicus London |
|
Ferring |
Gonapeptyl and Norprolac |
Fertility |
MJL Advertising |
|
GlaxoSmithKline |
Intergrilin |
Cardiovascular |
Medicus London |
|
Mencap |
Corporate |
Learning disabilities |
MJL Advertising |
|
Merck Pharma |
Glucophage SR |
Diabetes |
PBC Comms |
|
Merck Sharp & Dohme |
Maxalt |
Migraine |
PAN Advertising |
|
Novartis |
Glivec |
GIST |
PBC Comms |
|
Novartis |
Zometa |
Bone metastases |
PBC Comms |
|
Novartis |
Fortekor |
CHF |
MJL Advertising |
|
Otsuka Pharmaceuticals |
Pletal |
Pain |
Brand(x) |
|
Pfizer |
Celebrex |
Pain |
Medicus London |
|
sanofi-aventis |
Eloxatin |
Oncology |
Medicus London |
|
sanofi-aventis |
Epilim |
Epilepsy |
Medicus London |
|
sanofi-aventis |
Depakote |
Bipolar disorder |
Medicus London |
|
sanofi-aventis |
Aprovel |
Hypertension |
Medicus London |
|
sanofi-aventis |
Fasturtec |
Hyperuricaemia |
Medicus London |
|
Servier Laboratories |
Procoralan |
Cardiovascular |
PAN Advertising |
|
Solvay |
Omacor |
Cardiovascular |
Life |
Share
Related Hub content
Subscribe to our email news alerts
- Medscape Education’s Large Presence at IDWeek 2023
- WHO recommends second malaria vaccine for children
- Sanofi enters agreement with Janssen to develop E. coli vaccine candidate
- NFID and CDC urge US adults to get vaccinated against flu and COVID-19
- Man vs microbe: the fight against antimicrobial resistance
- Dollo's law
No results were found
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
- HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
- In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach....
